EA202091878A2 - NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY OF LUNG CANCER, INCLUDING NON-SMALL CELL LUNG CANCER (NSCLC) AND OTHER TYPES OF CANCER - Google Patents
NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY OF LUNG CANCER, INCLUDING NON-SMALL CELL LUNG CANCER (NSCLC) AND OTHER TYPES OF CANCERInfo
- Publication number
- EA202091878A2 EA202091878A2 EA202091878A EA202091878A EA202091878A2 EA 202091878 A2 EA202091878 A2 EA 202091878A2 EA 202091878 A EA202091878 A EA 202091878A EA 202091878 A EA202091878 A EA 202091878A EA 202091878 A2 EA202091878 A2 EA 202091878A2
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- peptides
- lung cancer
- cancer
- cells
- immunotherapy
- Prior art date
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Настоящее изобретение относится к пептидам, белкам, нуклеиновым кислотам и клеткам для применения в иммунотерапевтических методах. В частности, настоящее изобретение относится к иммунотерапии рака. Настоящее изобретение относится далее к опухолеассоциированным пептидным эпитопам Т-клеток, в отдельности или в комбинации с другими опухолеассоциированными пептидами, которые могут, например, служить в качестве активных фармацевтических ингредиентов вакцинных композиций, стимулирующих противоопухолевые иммунные ответы, или стимулировать Т-клетки ex vivo с их перенесением в организм пациента. Пептиды, связанные с молекулами главного комплекса гистосовместимости (МНС), или пептиды в отдельности могут быть также мишенями антител, растворимых Т-клеточных рецепторов и других связывающих молекул.The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to cancer immunotherapy. The present invention further relates to tumor-associated peptide epitopes of T cells, alone or in combination with other tumor-associated peptides, which can, for example, serve as active pharmaceutical ingredients in vaccine compositions that stimulate anti-tumor immune responses, or stimulate T cells ex vivo with their transfer to the patient's body. Peptides bound to major histocompatibility complex (MHC) molecules or peptides alone can also be targets for antibodies, soluble T-cell receptors, and other binding molecules.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562152258P | 2015-04-24 | 2015-04-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
EA202091878A2 true EA202091878A2 (en) | 2020-11-30 |
EA202091878A3 EA202091878A3 (en) | 2020-12-30 |
Family
ID=73649872
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA202091878A EA202091878A3 (en) | 2015-04-24 | 2016-04-22 | NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY OF LUNG CANCER, INCLUDING NON-SMALL CELL LUNG CANCER (NSCLC) AND OTHER TYPES OF CANCER |
EA202091864A EA202091864A3 (en) | 2015-04-24 | 2016-04-22 | NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY OF LUNG CANCER, INCLUDING NON-SMALL CELL LUNG CANCER (NSCLC) AND OTHER TYPES OF CANCER |
EA202091879A EA202091879A3 (en) | 2015-04-24 | 2016-04-22 | NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY OF LUNG CANCER, INCLUDING NON-SMALL CELL LUNG CANCER (NSCLC) AND OTHER TYPES OF CANCER |
EA202091863A EA202091863A3 (en) | 2015-04-24 | 2016-04-22 | NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY OF LUNG CANCER, INCLUDING NON-SMALL CELL LUNG CANCER (NSCLC) AND OTHER TYPES OF CANCER |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA202091864A EA202091864A3 (en) | 2015-04-24 | 2016-04-22 | NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY OF LUNG CANCER, INCLUDING NON-SMALL CELL LUNG CANCER (NSCLC) AND OTHER TYPES OF CANCER |
EA202091879A EA202091879A3 (en) | 2015-04-24 | 2016-04-22 | NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY OF LUNG CANCER, INCLUDING NON-SMALL CELL LUNG CANCER (NSCLC) AND OTHER TYPES OF CANCER |
EA202091863A EA202091863A3 (en) | 2015-04-24 | 2016-04-22 | NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY OF LUNG CANCER, INCLUDING NON-SMALL CELL LUNG CANCER (NSCLC) AND OTHER TYPES OF CANCER |
Country Status (1)
Country | Link |
---|---|
EA (4) | EA202091878A3 (en) |
-
2016
- 2016-04-22 EA EA202091878A patent/EA202091878A3/en unknown
- 2016-04-22 EA EA202091864A patent/EA202091864A3/en unknown
- 2016-04-22 EA EA202091879A patent/EA202091879A3/en unknown
- 2016-04-22 EA EA202091863A patent/EA202091863A3/en unknown
Also Published As
Publication number | Publication date |
---|---|
EA202091879A2 (en) | 2020-11-30 |
EA202091863A3 (en) | 2020-12-30 |
EA202091863A2 (en) | 2020-11-30 |
EA202091864A3 (en) | 2020-12-30 |
EA202091878A3 (en) | 2020-12-30 |
EA202091879A3 (en) | 2020-12-30 |
EA202091864A2 (en) | 2020-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2022005060A (en) | Novel peptides and combination of peptides for use in immunotherapy against lung cancer, including nsclc and other cancers. | |
EA202191027A2 (en) | NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY OF SEVERAL TUMORS | |
EA201992664A3 (en) | NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY OF OVARIAN CANCER AND OTHER TYPES OF CANCER | |
PH12018501865A1 (en) | Peptides and combination of peptides for use in immunotherapy against non-small cell lung cancer and other cancers | |
EA201890635A1 (en) | PEPTIDES AND COMBINATIONS OF PEPTIDES FOR APPLICATION IN IMMUNOTHERAPY OF SMALL CELLS OF LUNG AND OTHER CANCER SPECIES | |
EA202091878A3 (en) | NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY OF LUNG CANCER, INCLUDING NON-SMALL CELL LUNG CANCER (NSCLC) AND OTHER TYPES OF CANCER | |
EA201992860A1 (en) | NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR APPLICATION IN LUNG CANCER IMMUNOTHERAPY, INCLUDING NON-SMALL CELL LUNG CANCER (NSCLC), SMALL-CELL LUNG CANCER (MRL) AND OTHER | |
EA202092502A2 (en) | NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY OF SEVERAL TYPES OF CANCER | |
EA202191120A2 (en) | PEPTIDES AND THEIR COMBINATIONS FOR USE IN IMMUNOTHERAPY OF CANCER | |
EA202190241A1 (en) | NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY OF CLL AND OTHER TYPES OF CANCER | |
EA202190465A2 (en) | NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY NHL AND OTHER TYPES OF CANCER | |
EA202191013A3 (en) | NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY AND METHODS FOR OBTAINING FRAMEWORK FOR USE IN TREATMENT OF PANCREAS CANCER AND OTHER TYPES OF CANCER | |
EA202190896A2 (en) | NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY OF PANCREAS CANCER AND OTHER TYPES OF CANCER | |
EA202190186A1 (en) | PEPTIDES, COMBINATIONS OF PEPTIDES AND CELL-BASED MEDICINES FOR USE IN IMMUNOTHERAPY OF BLADDER CANCER AND OTHER TYPES OF CANCER | |
EA202092543A2 (en) | NEW PEPTIDES AND COMBINATIONS OF PEPTIDES AND FRAMEWORK FOR USE IN IMMUNOTHERAPY OF RENAL CELL CARCINOMA (RCC) AND OTHER TYPES OF CANCER |